{"id":1216190,"date":"2022-09-06T09:05:21","date_gmt":"2022-09-06T07:05:21","guid":{"rendered":"https:\/\/frezzapartners.com\/?p=1216190"},"modified":"2022-09-06T09:14:14","modified_gmt":"2022-09-06T07:14:14","slug":"e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax","status":"publish","type":"post","link":"https:\/\/frezzapartners.com\/en\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/","title":{"rendered":"E&#8217; stata approvata da AIFA la dose booster con vaccini bivalenti Comirnaty e Spikevax"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p>(<a href=\"https:\/\/www.aifa.gov.it\/-\/aifa-approva-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\">AIFA<\/a>) Nella seduta del 5 settembre 2022, la Commissione Tecnico Scientifica (CTS) di AIFA ha dato il via libera all\u2019utilizzo dei vaccini bivalenti Comirnaty e Spikevax, recentemente approvati da EMA come dosi booster per tutti i soggetti al di sopra dei dodici anni di et\u00e0.<\/p>\n<p>Tali vaccini, ha motivato la CTS, hanno mostrato la capacit\u00e0 di indurre una risposta anticorpale maggiore di quella del vaccino monovalente originario sia nei confronti della variante Omicron BA.1 che delle varianti BA.4 e BA.5.<\/p>\n<p>Sul piano della sicurezza i dati disponibili non mostrano differenze rispetto al vaccino monovalente originario.<\/p>\n<p>La dose booster \u00e8 disponibile per tutti i soggetti previsti dall\u2019indicazione autorizzata e pu\u00f2 essere somministrata dopo almeno tre mesi dal completamento del ciclo vaccinale primario o dall\u2019eventuale dose booster gi\u00e0 ricevuta.<\/p>\n<p>La CTS ha ribadito che la popolazione a maggior rischio di sviluppare malattia grave, per la quale quindi la dose booster \u00e8 fortemente raccomandata in via prioritaria, \u00e8 rappresentata dai soggetti che presentano fattori di rischio e dagli over 60.<\/p>\n<p>Tutti gli altri soggetti possono comunque vaccinarsi con la dose booster su consiglio del medico o come scelta individuale.<\/p>\n<p>Per maggiori dettagli clicca <a href=\"https:\/\/www.aifa.gov.it\/-\/aifa-approva-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\">qui<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; (AIFA) Nella seduta del 5 settembre 2022, la Commissione Tecnico Scientifica (CTS) di AIFA ha dato il via libera all\u2019utilizzo dei vaccini bivalenti Comirnaty e Spikevax, recentemente approvati da EMA come dosi booster per tutti i soggetti al di sopra dei dodici anni di et\u00e0. Tali vaccini, ha motivato la CTS, hanno mostrato la capacit\u00e0 di indurre una risposta anticorpale maggiore di quella del vaccino monovalente originario sia nei confronti della variante Omicron BA.1 che delle varianti BA.4 e&#8230;<\/p>\n","protected":false},"author":297440,"featured_media":1216192,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[141],"tags":[],"class_list":["post-1216190","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>E&#039; stata approvata da AIFA la dose booster con vaccini bivalenti Comirnaty e Spikevax - Frezza Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"E&#039; stata approvata da AIFA la dose booster con vaccini bivalenti Comirnaty e Spikevax - Frezza Partners\" \/>\n<meta property=\"og:description\" content=\"&nbsp; (AIFA) Nella seduta del 5 settembre 2022, la Commissione Tecnico Scientifica (CTS) di AIFA ha dato il via libera all\u2019utilizzo dei vaccini bivalenti Comirnaty e Spikevax, recentemente approvati da EMA come dosi booster per tutti i soggetti al di sopra dei dodici anni di et\u00e0. Tali vaccini, ha motivato la CTS, hanno mostrato la capacit\u00e0 di indurre una risposta anticorpale maggiore di quella del vaccino monovalente originario sia nei confronti della variante Omicron BA.1 che delle varianti BA.4 e...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/\" \/>\n<meta property=\"og:site_name\" content=\"Frezza Partners\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-06T07:05:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-06T07:14:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/frezzapartners.com\/wp-content\/uploads\/2022\/09\/vaccine-g1879993df_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1357\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Frezza Partners\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Frezza Partners\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\\\/\"},\"author\":{\"name\":\"Frezza Partners\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"headline\":\"E&#8217; stata approvata da AIFA la dose booster con vaccini bivalenti Comirnaty e Spikevax\",\"datePublished\":\"2022-09-06T07:05:21+00:00\",\"dateModified\":\"2022-09-06T07:14:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\\\/\"},\"wordCount\":203,\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/vaccine-g1879993df_1920.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\\\/\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\\\/\",\"name\":\"E' stata approvata da AIFA la dose booster con vaccini bivalenti Comirnaty e Spikevax - Frezza Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/vaccine-g1879993df_1920.jpg\",\"datePublished\":\"2022-09-06T07:05:21+00:00\",\"dateModified\":\"2022-09-06T07:14:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\\\/#primaryimage\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/vaccine-g1879993df_1920.jpg\",\"contentUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/vaccine-g1879993df_1920.jpg\",\"width\":1920,\"height\":1357},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/frezzapartners.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"E&#8217; stata approvata da AIFA la dose booster con vaccini bivalenti Comirnaty e Spikevax\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/\",\"name\":\"Frezza Partners\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/frezzapartners.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\",\"name\":\"Frezza Partners\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/en\\\/author\\\/fr3zz4partn3rs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"E' stata approvata da AIFA la dose booster con vaccini bivalenti Comirnaty e Spikevax - Frezza Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/","og_locale":"en_US","og_type":"article","og_title":"E' stata approvata da AIFA la dose booster con vaccini bivalenti Comirnaty e Spikevax - Frezza Partners","og_description":"&nbsp; (AIFA) Nella seduta del 5 settembre 2022, la Commissione Tecnico Scientifica (CTS) di AIFA ha dato il via libera all\u2019utilizzo dei vaccini bivalenti Comirnaty e Spikevax, recentemente approvati da EMA come dosi booster per tutti i soggetti al di sopra dei dodici anni di et\u00e0. Tali vaccini, ha motivato la CTS, hanno mostrato la capacit\u00e0 di indurre una risposta anticorpale maggiore di quella del vaccino monovalente originario sia nei confronti della variante Omicron BA.1 che delle varianti BA.4 e...","og_url":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/","og_site_name":"Frezza Partners","article_published_time":"2022-09-06T07:05:21+00:00","article_modified_time":"2022-09-06T07:14:14+00:00","og_image":[{"width":1920,"height":1357,"url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2022\/09\/vaccine-g1879993df_1920.jpg","type":"image\/jpeg"}],"author":"Frezza Partners","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Frezza Partners","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/#article","isPartOf":{"@id":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/"},"author":{"name":"Frezza Partners","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"headline":"E&#8217; stata approvata da AIFA la dose booster con vaccini bivalenti Comirnaty e Spikevax","datePublished":"2022-09-06T07:05:21+00:00","dateModified":"2022-09-06T07:14:14+00:00","mainEntityOfPage":{"@id":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/"},"wordCount":203,"image":{"@id":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2022\/09\/vaccine-g1879993df_1920.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/","url":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/","name":"E' stata approvata da AIFA la dose booster con vaccini bivalenti Comirnaty e Spikevax - Frezza Partners","isPartOf":{"@id":"https:\/\/frezzapartners.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/#primaryimage"},"image":{"@id":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2022\/09\/vaccine-g1879993df_1920.jpg","datePublished":"2022-09-06T07:05:21+00:00","dateModified":"2022-09-06T07:14:14+00:00","author":{"@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"breadcrumb":{"@id":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/#primaryimage","url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2022\/09\/vaccine-g1879993df_1920.jpg","contentUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2022\/09\/vaccine-g1879993df_1920.jpg","width":1920,"height":1357},{"@type":"BreadcrumbList","@id":"https:\/\/frezzapartners.com\/e-stata-approvata-da-aifa-la-dose-booster-con-vaccini-bivalenti-comirnaty-e-spikevax\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/frezzapartners.com\/"},{"@type":"ListItem","position":2,"name":"E&#8217; stata approvata da AIFA la dose booster con vaccini bivalenti Comirnaty e Spikevax"}]},{"@type":"WebSite","@id":"https:\/\/frezzapartners.com\/#website","url":"https:\/\/frezzapartners.com\/","name":"Frezza Partners","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/frezzapartners.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0","name":"Frezza Partners","url":"https:\/\/frezzapartners.com\/en\/author\/fr3zz4partn3rs\/"}]}},"_links":{"self":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1216190","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/users\/297440"}],"replies":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/comments?post=1216190"}],"version-history":[{"count":2,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1216190\/revisions"}],"predecessor-version":[{"id":1216194,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1216190\/revisions\/1216194"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media\/1216192"}],"wp:attachment":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media?parent=1216190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/categories?post=1216190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/tags?post=1216190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}